Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicaid Rx Spend Could Be Cut By Shifting To Actual Acquisition Costs, HHS Suggests

Executive Summary

State Medicaid agencies may be able to purchase drugs more efficiently by adopting the use of actual acquisition costs as the benchmark for reimbursement, HHS Secretary Kathleen Sebelius suggests in a letter to governors released Feb. 3.

You may also be interested in...



OIG And CMS Agree Medicaid Needs National Drug Price Benchmark Based On Acquisition Cost

With First DataBank scheduled to end publishing average wholesale price data in September, there is an opportunity for states to switch to pharmacy reimbursement based on actual acquisition costs.

Cutting Medicaid Costs: Texas, Other States Weigh Shift Of Rx Benefit To MCOs

In Texas, the government agency that operates the state’s Medicaid program is seeking action from the legislature to move operation of the Medicaid drug benefit to managed care organizations to reduce costs.

Cutting Medicaid Costs: Texas, Other States Weigh Shift Of Rx Benefit To MCOs

In Texas, the government agency that operates the state’s Medicaid program is seeking action from the legislature to move operation of the Medicaid drug benefit to managed care organizations to reduce costs.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS053121

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel